These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19041759)

  • 21. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
    Perrot V; Rechler MM
    Mol Endocrinol; 2005 Sep; 19(9):2283-98. PubMed ID: 15890677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development.
    Sekine K; Chen YR; Kojima N; Ogata K; Fukamizu A; Miyajima A
    EMBO J; 2007 Aug; 26(15):3607-15. PubMed ID: 17627282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.
    Matsuzaki H; Daitoku H; Hatta M; Aoyama H; Yoshimochi K; Fukamizu A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11278-83. PubMed ID: 16076959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.
    Brunet A; Sweeney LB; Sturgill JF; Chua KF; Greer PL; Lin Y; Tran H; Ross SE; Mostoslavsky R; Cohen HY; Hu LS; Cheng HL; Jedrychowski MP; Gygi SP; Sinclair DA; Alt FW; Greenberg ME
    Science; 2004 Mar; 303(5666):2011-5. PubMed ID: 14976264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
    Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
    Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we age on Sirt1 expression?
    Sedding D; Haendeler J
    Circ Res; 2007 May; 100(10):1396-8. PubMed ID: 17525376
    [No Abstract]   [Full Text] [Related]  

  • 27. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.
    Kobayashi Y; Furukawa-Hibi Y; Chen C; Horio Y; Isobe K; Ikeda K; Motoyama N
    Int J Mol Med; 2005 Aug; 16(2):237-43. PubMed ID: 16012755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.
    Wang F; Nguyen M; Qin FX; Tong Q
    Aging Cell; 2007 Aug; 6(4):505-14. PubMed ID: 17521387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.
    Schilling MM; Oeser JK; Boustead JN; Flemming BP; O'Brien RM
    Nature; 2006 Oct; 443(7111):E10-1. PubMed ID: 17024043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression.
    Ravnskjaer K; Kester H; Liu Y; Zhang X; Lee D; Yates JR; Montminy M
    EMBO J; 2007 Jun; 26(12):2880-9. PubMed ID: 17476304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice.
    Aoyama H; Daitoku H; Fukamizu A
    Int J Mol Med; 2006 Sep; 18(3):433-9. PubMed ID: 16865227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acid represses the peroxisome proliferator-activated receptor-gamma coactivator-1 promoter activity in a small heterodimer partner-dependent manner.
    Yamagata K; Yoshimochi K; Daitoku H; Hirota K; Fukamizu A
    Int J Mol Med; 2007 May; 19(5):751-6. PubMed ID: 17390079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
    Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
    Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor.
    Kamei Y; Miura S; Suganami T; Akaike F; Kanai S; Sugita S; Katsumata A; Aburatani H; Unterman TG; Ezaki O; Ogawa Y
    Endocrinology; 2008 May; 149(5):2293-305. PubMed ID: 18202130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SirT1 gain of function increases energy efficiency and prevents diabetes in mice.
    Banks AS; Kon N; Knight C; Matsumoto M; Gutiérrez-Juárez R; Rossetti L; Gu W; Accili D
    Cell Metab; 2008 Oct; 8(4):333-41. PubMed ID: 18840364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
    Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
    Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
    Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B
    Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Team demonstrates the rational design of drugs from RNA sequence.
    Coaker H
    Future Med Chem; 2014 Apr; 6(5):495. PubMed ID: 24795921
    [No Abstract]   [Full Text] [Related]  

  • 39. Healing the Heart with Sirtuins and Mammalian Forkhead Transcription Factors.
    Maiese K
    Curr Neurovasc Res; 2020; 17(1):1-2. PubMed ID: 31814554
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of gluconeogenic genes by calcium-regulated heat-stable protein 1 via repression of peroxisome proliferator-activated receptor α.
    Fan Y; Guo Y; Hamblin M; Chang L; Zhang J; Chen YE
    J Biol Chem; 2011 Nov; 286(47):40584-94. PubMed ID: 21990353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.